Who benefits when the government pays more? Pass-through in the Medicare Advantage program M Duggan, A Starc, B Vabson Journal of Public Economics 141, 50-67, 2016 | 166 | 2016 |
The consequences of health care privatization: evidence from Medicare Advantage exits M Duggan, J Gruber, B Vabson American Economic Journal: Economic Policy 10 (1), 153-186, 2018 | 88* | 2018 |
Health care rationing in public insurance programs: Evidence from Medicaid TJ Layton, N Maestas, D Prinz, B Vabson American Economic Journal: Economic Policy 14 (4), 397-431, 2022 | 37* | 2022 |
Rationing medicine through bureaucracy: authorization restrictions in medicare ZC Brot-Goldberg, S Burn, T Layton, B Vabson National Bureau of Economic Research, 2023 | 33 | 2023 |
The behavioral foundations of default effects: theory and evidence from Medicare Part D Z Brot-Goldberg, T Layton, B Vabson, AY Wang American Economic Review 113 (10), 2718-2758, 2023 | 28 | 2023 |
Comparison of care quality metrics in 2-sided risk Medicare Advantage vs fee-for-service Medicare programs K Cohen, O Ameli, CE Chaisson, K Catlett, J Chiang, A Kwong, ... JAMA network open 5 (12), e2246064-e2246064, 2022 | 7 | 2022 |
Efficiency Gains Under Incomplete Contracting: Evidence from Medicaid B Vabson Stanford Institute for Economic Policy Research Job Market Paper, 2017 | 6 | 2017 |
How Should Policymakers Respond To Growth In Cost Sharing That Often Goes Unpaid? B Ippolito, B Vabson Health Affairs Forefront, 2023 | 3 | 2023 |
Rationing Medicine Through Paperwork: Authorization Restrictions in Medicare Z Brot-Goldberg, T Layton, S Burn, B Vabson 2021 APPAM Fall Research Conference, 2022 | 2 | 2022 |
Predicting disability enrollment using machine learning T Layton, H Liebert, N Maestas, D Prinz, B Vabson NBER Working Paper No. NB18-Q4). National Bureau of Economic Research …, 2019 | 2 | 2019 |
Essays in health economics and public finance BV Vabson University of Pennsylvania, 2015 | 2 | 2015 |
How Do Prescription Drug Benefits Differ Between Medicare Advantage and Stand-Alone Part D Drug Plans? BN Ippolito, B Vabson < bound method Organization. get_name_with_acronym of< Organization …, 2024 | | 2024 |
Medicaid vs Medicare: Evidence from Medicaid to Medicare Transitions at 65 T Layton, N Maestas, D Prinz, M Shepard, B Vabson | | 2024 |
The value of improving insurance quality: Evidence from long-run Medicaid attrition A Lee, B Vabson Journal of Health Economics 94, 102865, 2024 | | 2024 |
Quality Outcomes Under Medicare Advantage vs. Medicare Fee-for-Service B Vabson, C Teigland, Z Pulungan, Y Su, Z Brot-Goldberg, S Bilder, ... AEI: American Enterprise Institute for Public Policy Research, 2024 | | 2024 |
Harvard-Inovalon Medicare Study: Utilization and Efficiency Under Medicare Advantage vs. Medicare Fee-for-Service B Vabson, S Bilder, ZC Brot-Goldberg, BT Jones, I Mohammadi, ... AEI: American Enterprise Institute for Public Policy Research, 2023 | | 2023 |
The Value of Improving Insurance Quality: Evidence from Long-Run Medicaid Attrition B Vabson, A Lee AEI: American Enterprise Institute for Public Policy Research, 2023 | | 2023 |
Estimating Variation in Productivity Across State Medicaid Programs: Evidence from Dual-Eligibles T Layton, N Maestas, D Prinz, M Shepard, B Vabson | | 2023 |
Rationing Medicine Through Bureaucracy: Authorization Restrictions in Medicare B Vabson, Z Brot-Goldberg, S Burn, T Layton AEI: American Enterprise Institute for Public Policy Research, 2023 | | 2023 |
HPR24 Characteristics, Healthcare Resource Utilization, Cost, and Quality Outcomes of Medicare Beneficiaries While Commercially Insured and after Transition to Medicare … C Teigland, Z Pulungan, I Mohammadi, BT Jones, S Bilder, ... Value in Health 26 (6), S215, 2023 | | 2023 |